tirzepatide schweiz FDA Grants a New Indication for Obesity Management Weight-loss drug tirzepatide may lower

and affiliated professional entities are the independent medical groups providing the actual clinical care

Tirzepatide acts on GIP and GLP-1 receptors to help control insulin release and appetite

Participants who continued treatment maintained significantly more weight loss than those who transitioned to placebo, reinforcing that tirzepatides benefits are dependent on ongoing use and that no new or unexpected safety signals emerged with extended treatment duration

What To Do If Side Effects Feel Excessive Or Persistent If symptoms are severe, stop the medication and contact your clinician or go to emergency care for immediate evaluation

-2.1% with placebo, with 64% vs

To help ease side effects, we recommend: Eating smaller, slower meals Prioritizing protein and staying well hydrated Avoiding greasy, heavy, or highly processed foods Not lying down immediately after eating Staying at the lowest effective dose for as long as appetite suppression is working If side effects feel intolerable , persistent, or unusual, or if something simply doesnt feel right, please contact your provider right away